Hepatitis C Virus
Hepatitis C is a virus that often silently attacks your liver. Most people infected with the hepatitis C virus (HCV) have no symptoms at all. In fact, most people don't know they have the disease until liver damage shows up, decades later, during routine medical tests.
Hepatitis C is one of six identified hepatitis viruses — the others are A, B, D, E and G. All cause the liver to become inflamed, which interferes with its ability to function. Hepatitis C is generally considered to be among the most serious of these viruses.
The Hepatitis C (HCV) virus was identified in 1989. Unlike the other types of viral hepatitis, hepatitis C is very difficult for the immune system to overcome. As a result, most Hepatitis C infections (80-90%) become chronic and lead to liver disease, including cirrhosis (scarring of the liver tissues) and liver failure. Hepatitis C infection is typically mild in its early stages, and it is rarely recognized until it has caused significant damage to the liver. The cycle of disease from infection to significant liver damage can take 20 years or more.
Further research has determined that the Hepatitis C virus (HCV) is an enveloped RNA virus in the flavivirdae family. HCV infection is the most common chronic blood borne infection in the United States and globally.
Hepatitis C can be either “acute” or “chronic.” Acute hepatitis C virus infection is a short-term illness that occurs within the first 6 months after someone is exposed to the hepatitis C virus. For most people, acute infection leads to chronic infection. Chronic hepatitis C is a serious disease than can result in long-term health problems, or even death.
HCV is transmitted primarily through large or repeated direct percutaneous exposures to blood. Historically, blood transfusions accounted for a substantial proportion of HCV infections, however, improved donor screening and blood testing has dramatically reduced the risk of HCV transmission. Since 1994, the CDC’s viral hepatitis system has been unable to detect any transfusion-associated cases of acute HCV. Intravenous drug use currently accounts for most HCV transmissions and both incidence and prevalence of HCV remains high in this group.
Over time, if you have a hepatitis C infection, it can lead to liver cancer, liver failure or cirrhosis-irreversible and potentially fatal scarring of the liver.
Unlike HIV, the hepatitis C virus usually isn't transmitted through sexual contact. Instead, you're more at risk if you're exposed to contaminated blood — through needles shared during drug use or through blood transfusions. Although vaccines exist for hepatitis A and B, no vaccine for hepatitis C has been developed. Researchers hope to find a medication that will slow or stop the growth of the virus and prevent long-term complications, such as cirrhosis and cancer, from developing. Nexco feels strongly that Nexavir should undergo clinical testing as a treatment for hepatitis C.
Symptoms
Early stage signs and symptoms
Hepatitis C infection commonly produces no signs or symptoms during its earliest stages. When it does, they're generally mild and flu-like and may include:
Slight Fatigue
Nausea Or Poor Appetite
Muscle And Joint Pains
Tenderness In Liver
Later stage signs and symptoms
Even if you develop chronic hepatitis from the hepatitis C virus, you may have few, if any, symptoms. In many cases, signs and symptoms may not appear for decades. Sometimes, though, you may experience one or more of the following:
Fatigue
Lack Of Appetite
Nausea And Vomiting
Low-Grade Fever
Persistent Or Recurring Yellowing Of Your Skin And Eyes (Jaundice)
Causes
Hepatitis C can cause damage to your liver, even if you don't have symptoms. You're also able to pass the virus to others without having any symptoms yourself. That's why it's important to be tested if you think you've been exposed to hepatitis C or if you engage in behavior that puts you at risk.
- In general, you get hepatitis C by coming in contact with blood contaminated with the virus. Most people with hepatitis C became infected through blood transfusions received before 1992, the year improved blood-screening tests became available.
- Hepatitis means inflammation of the liver. Toxins, certain drugs, some diseases, heavy alcohol use, and bacterial and viral infections can all cause hepatitis C.
Hepatitis C Treatment
Hepatitis C treatment has evolved with the development of therapies that specifically target the hepatitis C virus (HCV). Direct-acting antiviral medicines (DAAs) are commonly used as oral treatment options and work by interfering with different stages of the viral life cycle.
The choice of Hepatitis C treatment can vary based on factors such as HCV genotype, liver condition, previous treatment, other medications, and individual treatment requirements. Testing and clinical assessment can help determine the most appropriate treatment approach and support ongoing monitoring during therapy.
Timely diagnosis and appropriate treatment are important steps in managing Hepatitis C and may help reduce the risk of liver-related complications associated with persistent HCV infection.
Can Hepatitis C Be Prevented?
There is currently no effective vaccine against hepatitis C. Prevention therefore focuses on reducing exposure to infected blood.
Important prevention measures include using sterile injection equipment, ensuring appropriate infection-control practices, screening blood products, and avoiding the sharing of personal items that may contain blood, such as razors or toothbrushes.
Hepatitis C Testing and Early Detection
Because HCV infection frequently causes no symptoms, testing plays an important role in identifying infection. A person may have hepatitis C without knowing it and may only discover the infection through routine screening or testing following a possible exposure.
Identifying HCV early provides an opportunity to evaluate the infection and access effective treatment before significant liver damage develops.
Hepatitis C and Long-Term Liver Health
Untreated chronic hepatitis C can gradually affect liver health. Regular medical evaluation can help identify liver damage and determine whether treatment is appropriate.
Maintaining healthy habits, avoiding excessive alcohol consumption, and following appropriate medical guidance can also support overall liver health.
Research on Hepatitis C and Nexavir
Nexavir is formulated with processed porcine liver extract and has been used in clinical practice. Its properties have been explored in areas involving viral activity, inflammatory processes, and immune-system responses.
Nexco Pharma has expressed interest in further clinical investigation of Nexavir in relation to hepatitis C. This should be distinguished from established hepatitis C treatments: current evidence supports direct-acting antiviral medicines as the standard curative treatment for HCV infection.
Explore Nexavir and Hepatitis C Research
Hepatitis C is a viral infection that primarily affects the liver and may develop into a long-term condition when the virus remains in the body. Learning about HCV, its symptoms, transmission, diagnosis, and available treatment options can help build a better understanding of the infection.
Nexavir features processed porcine liver extract as its core ingredient and has been utilized in clinical practice. Scientific interest in the product has covered several biological areas, including interactions with viral processes, inflammatory activity, and immune-system function. Research in these fields continues to contribute to a broader understanding of Nexavir and its possible relevance to viral conditions such as hepatitis C.
Interested in exploring the product further? Review information about Nexavir’s formulation, ingredients, development, and research history. The Nexavir product section and Research & Uses resources offer additional details about the subjects that have been investigated.
Explore Nexavir and learn more about the research and information surrounding its potential applications.
Frequently Asked Questions
Hepatitis C is a viral infection caused by the hepatitis C virus (HCV). It mainly affects the liver and can develop into either an acute or chronic infection.
Many people with hepatitis C may not notice symptoms. When symptoms occur, they can include fatigue, nausea, loss of appetite, abdominal discomfort, dark urine, joint pain, and yellowing of the skin or eyes.
Hepatitis C is primarily spread through contact with infected blood. Sharing contaminated needles or injection equipment and exposure to improperly sterilized equipment are possible routes of transmission.
Yes. Some people do not clear HCV naturally after an acute infection and may develop chronic hepatitis C. Long-term infection can increase the risk of liver damage and other complications.
Hepatitis C is diagnosed through blood testing. An HCV antibody test can identify previous exposure, while an HCV RNA test can determine whether the virus is currently present.
Currently, there is no effective vaccine that prevents hepatitis C. Prevention focuses on reducing exposure to infected blood.
Long-term HCV infection can contribute to liver fibrosis, cirrhosis, liver failure, and an increased risk of liver cancer.
Nexavir is formulated with processed porcine liver extract and has been used in clinical practice. Its properties have been explored in areas involving viral processes, inflammation, and immune-system activity.
Nexavir has been an area of research interest in connection with viral conditions, including hepatitis C. Research has explored properties related to viral activity, inflammatory processes, and immune responses.
You can explore the Nexavir product and Research & Uses sections to learn more about its formulation, ingredients, background, and available research related to viral conditions.